| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
|
Bone Marrow Transplant
|
2010
|
3.46
|
|
2
|
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection.
|
Antimicrob Agents Chemother
|
2006
|
2.31
|
|
3
|
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.
|
Clin Microbiol Infect
|
2014
|
2.06
|
|
4
|
Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.
|
Infection
|
2012
|
2.02
|
|
5
|
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.
|
Clin Microbiol Infect
|
2014
|
1.70
|
|
6
|
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).
|
Clin Microbiol Infect
|
2012
|
1.55
|
|
7
|
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
|
Clin Microbiol Infect
|
2012
|
1.48
|
|
8
|
[Clinical research in orthopaedics--creation of a clinical trial unit in orthopaedics/trauma surgery].
|
Z Orthop Unfall
|
2010
|
1.45
|
|
9
|
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.
|
Clin Microbiol Infect
|
2012
|
1.41
|
|
10
|
[62-year-old patient with chronic lymphatic leukaemia and persistent fever in chemotherapy induced bone marrow aplasia. Angioinvasive aspergillosis].
|
Dtsch Med Wochenschr
|
2011
|
1.39
|
|
11
|
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.
|
Clin Microbiol Infect
|
2014
|
1.36
|
|
12
|
Forty-one recent cases of invasive zygomycosis from a global clinical registry.
|
J Antimicrob Chemother
|
2009
|
1.31
|
|
13
|
Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort.
|
J Antimicrob Chemother
|
2010
|
1.28
|
|
14
|
Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation.
|
Antimicrob Agents Chemother
|
2009
|
1.24
|
|
15
|
Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).
|
Ann Hematol
|
2003
|
1.23
|
|
16
|
Chronic pulmonary aspergillosis.
|
Mycoses
|
2013
|
1.17
|
|
17
|
Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B.
|
Ann Hematol
|
2003
|
1.07
|
|
18
|
Lack of evidence for exposure-response relationship in the use of posaconazole as prophylaxis against invasive fungal infections.
|
Clin Pharmacol Ther
|
2011
|
1.07
|
|
19
|
Acute anterior myocardial infarction as first manifestation of acute myeloid leukemia.
|
Ann Hematol
|
2001
|
1.01
|
|
20
|
Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.
|
Eur J Clin Microbiol Infect Dis
|
2004
|
0.99
|
|
21
|
Improvement in the outcome of invasive fusariosis in the last decade.
|
Clin Microbiol Infect
|
2013
|
0.99
|
|
22
|
Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients.
|
Epidemiol Infect
|
2011
|
0.98
|
|
23
|
Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).
|
Ann Oncol
|
2006
|
0.93
|
|
24
|
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases.
|
Clin Microbiol Infect
|
2012
|
0.93
|
|
25
|
Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the german society of haematology and oncology.
|
Ann Oncol
|
2005
|
0.93
|
|
26
|
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany.
|
Euro Surveill
|
2012
|
0.92
|
|
27
|
Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients.
|
J Antimicrob Chemother
|
2005
|
0.91
|
|
28
|
Evaluation of an infectious disease consultation programme in a German tertiary care hospital.
|
Infection
|
2013
|
0.87
|
|
29
|
Management of infections during intensive treatment of hematologic malignancies.
|
Ann Hematol
|
1997
|
0.86
|
|
30
|
A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II.
|
Infection
|
2006
|
0.86
|
|
31
|
Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study.
|
J Hosp Infect
|
2011
|
0.86
|
|
32
|
Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.
|
Mycoses
|
2011
|
0.85
|
|
33
|
Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
|
Infection
|
2005
|
0.85
|
|
34
|
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS.
|
Clin Microbiol Infect
|
2012
|
0.85
|
|
35
|
Causes of death in HIV-infected patients from the Cologne-Bonn cohort.
|
Infection
|
2013
|
0.84
|
|
36
|
Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals.
|
Mycoses
|
2012
|
0.83
|
|
37
|
Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive Aspergillosis enhances diagnostic capabilities.
|
J Clin Microbiol
|
2013
|
0.83
|
|
38
|
Infectious diseases publications in leading medical journals--a comparative analysis.
|
Eur J Clin Microbiol Infect Dis
|
2012
|
0.82
|
|
39
|
Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
|
Mycoses
|
2015
|
0.82
|
|
40
|
Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials.
|
Eur J Clin Microbiol Infect Dis
|
2009
|
0.81
|
|
41
|
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.
|
Eur J Clin Microbiol Infect Dis
|
2012
|
0.80
|
|
42
|
Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome.
|
Eur J Clin Pharmacol
|
2012
|
0.79
|
|
43
|
Liver involvement in HIV-infected patients diagnosed with syphilis.
|
Infection
|
2012
|
0.79
|
|
44
|
Late onset of Leber's hereditary optic neuropathy in HIV infection.
|
Br J Ophthalmol
|
1999
|
0.78
|
|
45
|
Current issues in the clinical management of invasive aspergillosis--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.
|
Mycoses
|
2011
|
0.78
|
|
46
|
Practical considerations on current guidelines for the management of non-neutropenic adult patients with candidaemia.
|
Mycoses
|
2012
|
0.77
|
|
47
|
Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole.
|
Eur J Clin Microbiol Infect Dis
|
2014
|
0.77
|
|
48
|
ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associations.
|
Clin Exp Rheumatol
|
2004
|
0.76
|
|
49
|
Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.
|
Infection
|
2013
|
0.75
|
|
50
|
Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
|
Ann Oncol
|
2013
|
0.75
|
|
51
|
Acceptance and tolerability of an adjuvanted nH1N1 vaccine in HIV-infected patients in the Cologne-Bonn cohort.
|
Eur J Med Res
|
2011
|
0.75
|
|
52
|
[Posaconazole: another triazole antifungal of the new generation?].
|
Dtsch Med Wochenschr
|
2008
|
0.75
|
|
53
|
Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in Germany.
|
Transpl Infect Dis
|
2014
|
0.75
|
|
54
|
Successful treatment of chronic disseminated candidiasis with caspofungin and itraconazole in a patient with progressive acute leukemia and prolonged neutropenia.
|
Int J Hematol
|
2004
|
0.75
|
|
55
|
Making moulds meet. Information retrieval as a basis for understanding Pseudallescheria and Scedosporium.
|
Mycoses
|
2011
|
0.75
|
|
56
|
[Prediction of overactive bladder treatment outcome by using long-term urodynamics].
|
Urologe A
|
2014
|
0.75
|
|
57
|
[The curriculum for rotation physicians within the CHIR-Net].
|
Chirurg
|
2009
|
0.75
|
|
58
|
Ceftriaxone in febrile neutropenia.
|
J Chemother
|
2003
|
0.75
|
|
59
|
Failure of anti-infective mouth rinses and concomitant antibiotic prophylaxis to decrease oral mucosal colonization in autologous stem cell transplantation.
|
Bone Marrow Transplant
|
2005
|
0.75
|
|
60
|
Clinical course and quality of care in ART-naïve patients newly presenting in a HIV outpatient clinic.
|
Infection
|
2014
|
0.75
|
|
61
|
[Antimicrobial therapy of febrile neutropenia--current developments].
|
Wien Med Wochenschr
|
2001
|
0.75
|
|
62
|
[Invasive candidiasis in non-neutropenic adults : Guideline-based management in the intensive care unit].
|
Anaesthesist
|
2013
|
0.75
|